Why AI matters at this scale

The Ohio State University Comprehensive Cancer Center – James Cancer Hospital & Solove Research Institute is a large academic medical center dedicated to oncology patient care, research, and education. With over 1,000 employees, it operates at a scale where manual processes and generalized treatment protocols become significant bottlenecks. AI presents a transformative lever to personalize medicine, optimize expensive resources, and accelerate discovery. For an institution of this size and mission, leveraging AI is not just an efficiency play but a strategic imperative to improve survival rates, control the high costs of cancer care, and maintain its competitive edge in groundbreaking research.

Concrete AI opportunities with ROI framing

1. Predictive Analytics for Treatment Personalization: By applying machine learning to integrated electronic health records (EHR), genomic data, and medical imaging, the center can develop models that predict individual patient responses to therapies and potential complications. The ROI is substantial: reduced trial-and-error in treatment selection can lower costs from ineffective therapies and manage side effects earlier, improving patient outcomes and satisfaction. For a large hospital, even a small percentage reduction in readmissions or emergency visits translates to major financial savings.

2. Automated Clinical Trial Matching: Patient enrollment is a chronic bottleneck in oncology research. Natural language processing (NLP) AI can automatically and continuously screen EHR data against complex trial eligibility criteria. This directly accelerates the research pipeline, bringing new therapies to market faster. The ROI includes increased grant funding from higher enrollment, more publications, and enhanced prestige as a top trial site, attracting both patients and pharmaceutical partnerships.

3. Operational Workflow Optimization: AI-driven forecasting models for patient admission, bed capacity, and staff scheduling can smooth operations in a large, unpredictable cancer hospital. Predictive maintenance for expensive equipment like MRI and linear accelerators minimizes downtime. The ROI is clear in better asset utilization, reduced overtime costs, improved patient flow, and higher staff morale—directly impacting the bottom line for a 1,000+ employee organization.

Deployment risks specific to this size band

Large healthcare organizations like The James face unique AI deployment challenges. Data Silos: Clinical, research, and operational data are often stored in disparate systems (e.g., Epic EHR, research databases, supply chain software), making unified data lakes for AI training complex and expensive. Regulatory and Compliance Hurdles: Any AI touching patient care must navigate HIPAA, and if intended as a medical device, FDA clearance. This lengthens development cycles and requires robust governance. Change Management: Rolling out AI tools to a large, diverse staff of clinicians, researchers, and administrators requires extensive training and can meet resistance if not aligned with existing workflows. Integration Costs: At this scale, pilot projects must be engineered for enterprise-wide integration from the start, requiring significant upfront investment in MLOps and IT infrastructure, which can delay time-to-value.